第2回CIBER主催ウェビナー：
COVID関連研究／開発：海外バイオバンクにおけるCOVID-19検体
バンキングと、対COVID-19研究開発の現状
The 2nd CIBER Webinar
Covid-19 research and biobanking activities across the globe
終了いたしました。
開催趣旨 Introduction
第1回ウェビナーでは日本国内バイオバンクにおけるCOVID-19収集状況や研究開発についての現状を共有し、活発な議論を通じて今後の研究開発の進め方について考察を深めることができました。第2回ウェビナーでは海外のバイオバンクの活動にフォーカスし、欧州と豪州から演者をお招きし、対COVID研究開発活動の促進のために、さらに考察を深める場となることを期待しています。バイオバンク、ウイルス／ゲノム解析研究者、企業の方の多数のご参加をお待ちしております。※追加講演決定！中国バイオバンクの演者による追加講演と協賛セミナー追加演題決定。
At the 1st Webinar, we shared the current status of COVID-19 collection and research and development at biobanks in Japan, and were able to deepen our consideration of how to proceed with future research and development through lively discussions. At the 2nd Webinar, we will focus on the activities of overseas biobanks. Speakers from Europe, Australia and China will introduce their biobanking activities. Also, in the corporate seminars, the new technology and tools will be introduced to support and contribute to overall bio-research. We look forward to the participation of biobanks, virus/genome analysis researchers, and companies!
| 日時 | 2020年11月13日（金） 17時00分～19時00分 |
|---|---|
| Date & Time | November 13, 2020, Friday 17:00~19:00 (Japan Standard Time) |
| 会議方式 |
Web 会議システム（zoom ウェビナー）
ウェビナーのリンク先は、11月11日～12日付でメールで
送信させていただきました。 お心あたりのない方は迷惑メールフォルダー等もご確認ください。
差出人：CIBER事務局
件名：【ウェビナーご参加方法】 「COVID関連研究／開発：海外バイオバンクにおける COVID-19検体バンキングと、対COVID-19研究開発の現状」 |
| Format | Zoom Webinar |
| 参加者 | 500名まで（参加者は先着順とさせていただきます） |
| Participation | Up to 500 |
| 参加費 | 無料 |
| Registration Fee | Free |
| 参加申し込み 締め切り |
2020年11月11日18時 終了いたしました |
| Registration Deadline |
November 11, 2020, 18:00 (Japan Standard Time) |
プログラム Program
| ファシリテーター: | 中江裕樹 特定非営利活動法人 バイオ計測技術コンソーシアム(JMAC)事務局長／ 日本生物資源産業利用協議会(CIBER)理事 |
| Facilitator: | Dr. Hiroki Nakae, JMAC & CIBER |
|
演者 Speaker
|
内容 Topic
|
|---|---|
|
小林孝史氏 イルミナ株式会社 営業本部技術営業部 |
協賛セミナー Corporate Seminar
次世代シーケンサーによるゲノム解析が新型コロナウイルス感染症対策にもたらすインパクト
|
| Takafumi Kobayashi, PhD Senior Applied Genomics Specialist, APJ sales specialist team, Illumina |
The benefit of NGS-based genome analysis on combating COVID-19 |
| Dr. Stefano Ongarello, Head of Data Services & Biobanking at FIND (Switzerland） |
A COVID-19 biobank network to support the development and validation of diagnostics |
|
高木 智史氏 バイオ・アクセラレーター株式会社 代表取締役 |
協賛セミナー Corporate Seminar
東北大学Covid19呼気OMICS診断データベース構築 |
| Mr. Satoshi Takagi, CEO, Bio-xcelerator, Partner of BC Platforms | New Covid19 Diagnostics by Breath Omics and DWH at Tohoku University |
| Dr. Xun Xu China National Genebank |
Biobanking and Covid-19 Research at BGI, China |
|
松本洋亮氏、廣畑吉崇氏 住商ファーマインターナショナル株式会社 |
協賛セミナー Corporate Seminar
COVID-19研究を加速する研究手法の動向
～全血採取培養デバイス・免疫応答の特性解析の活用を中心に～ |
| Mr. Yosuke Matsumoto, Mr. Yoshitaka Hirohata Summit Pharmaceauticals International Corporation |
COVID-19 research acceleration by whole blood culture device and characteristic analysis of immune response |
| Dr. Daniel Catchpoole, ISBER President, The Tumour Bank, The Children’s Hospital at Westmead (Australia) |
Waiting for the tidal wave: Biobanking for COVID19 research ‘Down Under’ |
| 総合討論 Discussion |
発表順序は変更になる可能性がございます。Order is subject to change.
演者 Speakers
 |
Dr. Stefano Ongarello, Head of Data Services & Biobanking at FIND Dr Stefano Ongarello leads the Data Services and Biobanking team at FIND, overseeing all activities relating to data science, statistical analysis and support for clinical trials, and data collection and management. He is also responsible for the FIND biobank, including the supervision of sample collection and distribution, and the organization’s virtual biobank platform. Prior to this position, he focused on data science for pharmaceutical development, in particular the development and implementation of personalized medicine in oncology through statistical analysis and machine learning. He received a MD in Computer Science, and a PhD in Bioengineering, both from the University of Padova, Italy. |
 |
Dr. Daniel Catchpoole, ISBER President, The Tumour Bank, The Children’s Hospital at Westmead (Australia) Associate Professor Dan Catchpoole is Head of the Tumour Bank at The Children’s Hospital at Westmead, Sydney Australia and is the current President of The International Society for Biological and Environmental Repositories. A cancer cell biology specialist A/Prof Catchpoole has lead a rare disease biobanking focussing on childhood cancer. His biobank has become one of the premier biobanking facilities in Australia that has supported over 100 international projects into pediatric malignancy. A/Prof Catchpoole is one of the founding members of the Australasian Biospecimens Network Association. His research interest focus on the panomic assessment of childhood cancer to facilitate personalised medicine that will lead to improved treatment certainty for clinicians. (Youtube Introduction: http://www.youtube.com/watch?v=mPXJYWQNgBI) |
 |
Dr. Xun Xu, China National Genebank Dr. Xun Xu is the chief executive officer of the global genomics organization BGI, president and chief scientist of BGI-Research. Dr. Xu is also nominated as Vice-Chairman of International Organization for Standardization/Biotechnology Committee (ISO/TC276), and Director-at-Large-China of International Society for Biological and Environmental Repositories (ISBER). His research focuses on the genetic sequencing technologies, single-cell sequencing, DNA synthesizer and the applications of sequencing technologies in disease management and agriculture. He has authored or co-authored 223 scientific papers published in top peer-reviewed journals listed in SCI including Nature, Science, and Cell. Dr. Xu has led 15 major national scientific research projects and several international projects, including China National 863 Sequencing Instrument Development Project and Million Microbiome of Humans Project (MMHP). |
協賛企業 Sponsors
BC Platforms AG
ブルックス・ジャパン株式会社
株式会社椿本チエイン
イルミナ株式会社
住商ファーマインターナショナル株式会社
後援 Patronage
クリニカルバイオバンク学会（Society of Clinical Biobank)